Rafarma Pharmaceuticals

Rafarma Pharmaceuticals RAFA Stock

$0.01   -14.423079%
Add to favorites
Market Cap
$781.13K
LOW - HIGH [24H]
$0.01 - $0.01
VOLUME [24H]
$7.13K
P/E Ratio
0
Earnings per share
-$0.01
ISIN
US75062C1009

Rafarma Pharmaceuticals Price Chart

Sorry, that's all we've gotfor now...

Rafarma Pharmaceuticals (RAFA) stock price today is 0.0089 USD on OTC Markets OTCPK (-14.42% on the day). Updated .

Rafarma Pharmaceuticals RAFA Financial and Trading Overview

Rafarma Pharmaceuticals stock price 0.0089 USD
Previous Close 0.009 USD
Open 0.01 USD
Bid 0.009 USD x 1000000
Ask 0.01 USD x 1000000
Day's Range 0.01 - 0.01 USD
52 Week Range 0.004 - 0.09 USD
Volume 62.5K USD
Avg. Volume 19.58K USD
Market Cap 1.05M USD
Beta (5Y Monthly) 0.965
PE Ratio (TTM) N/A
EPS (TTM) -0.014 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est N/A

RAFA Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 7.8990498
Price/Book (mrq) 0.00029639143
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Rafarma Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.965
52-Week Change -67.56%
S&P500 52-Week Change 13.32%
52 Week High 0.09 USD
52 Week Low 0.004 USD
50-Day Moving Average 0.03 USD
200-Day Moving Average 0.04 USD

RAFA Share Statistics

Avg. Volume (3 month) 19.58K USD
Avg. Daily Volume (10-Days) 65.91K USD
Shares Outstanding 87.77M
Float N/A
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2012
Most Recent Quarter (mrq) N/A
Next Fiscal Year End March 31, 2013

Profitability

Profit Margin -87.91%
Operating Margin (ttm) -81.25%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -0.041%
Return on Equity (ttm) -0.071%

Income Statement

Revenue (ttm) 133.33K USD
Revenue Per Share (ttm) 0.02 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 0 USD
EBITDA N/A
Net Income Avi to Common (ttm) -117223 USD
Diluted EPS (ttm) -0.014
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 40.487

Cash Flow Statement

Operating Cash Flow (ttm) 25K USD
Levered Free Cash Flow (ttm) N/A

Profile of Rafarma Pharmaceuticals

Country United States
State UT
City Draper
Address 12465 South Fort St
ZIP 84020
Phone 307 429 2029
Website https://rafarma.co
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Rafarma Pharmaceuticals, Inc. engages in the development and production of medical equipment. It is also involved in the supply of equipment for hospitals and clinics. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company was incorporated in 1982 and is based in Draper, Utah. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.

Q&A For Rafarma Pharmaceuticals Stock

What is a current RAFA stock price?

Rafarma Pharmaceuticals RAFA stock price today per share is 0.0089 USD.

How to purchase Rafarma Pharmaceuticals stock?

You can buy RAFA shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Rafarma Pharmaceuticals?

The stock symbol or ticker of Rafarma Pharmaceuticals is RAFA.

Which industry does the Rafarma Pharmaceuticals company belong to?

The Rafarma Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.

How many shares does Rafarma Pharmaceuticals have in circulation?

The max supply of Rafarma Pharmaceuticals shares is 87.77M.

What is Rafarma Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Rafarma Pharmaceuticals PE Ratio is now.

What was Rafarma Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Rafarma Pharmaceuticals EPS is -0.014 USD over the trailing 12 months.

Which sector does the Rafarma Pharmaceuticals company belong to?

The Rafarma Pharmaceuticals sector is Healthcare.

$2.23T
Total marketcap
$76.4B
Total volume
BTC 58.66%   •   ETH 9.99%
Dominance
Select currency